Suchergebnisse - "Ramanan, Athimalaipet V."

PubPharm (28)

1

Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY) : a randomised, controlled, open-label, platform trial

enthalten in: The Lancet. Child & adolescent health | 2024

von RECOVERY Collaborative Group | Faust, S. | Haynes, R. | +98

2

Correction : Improving clinical paediatric research and learning from COVID-19: recommendations by the Conect4Children expert advice group

enthalten in: Pediatric research | 2023

von Ramanan, A. | Modi, N. | de Wildt, S. | +39

ErratumFor: Pediatr Res. 2022 Apr;91(5):1069-1077. - PMID 34099854

3

Efficacy and safety of baricitinib in patients with COVID-19 infection: Results from the randomised, double-blind, placebo-controlled, parallel-group COV-BARRIER phase 3 trial

enthalten in: bioRxiv.org | 2023

von Marconi, V. | Ramanan, A. | de Bono, S. | +16

4

Hiding in plain sight : how the COVID-19 pandemic unmasked the autoinflammatory PFAPA syndrome lurking in our midst

enthalten in: Archives of disease in childhood | 2023

von Sinnappurajar, P. | Ramanan, A. | Goenka, A.

5

Global Association of the COVID-19 Pandemic With Pediatric Clinical Trial Publication

enthalten in: JAMA network open | 2023

von Grantham-Hill, S. | Eyre, M. | Ramanan, A. | +3

6

SARS-CoV-2 vaccinations in children and adolescents with rheumatic diseases

enthalten in: Rheumatology (Oxford, England) | 2022

von Sen, E. | Julandani, D. | Ramanan, A.

CommentOn: Rheumatology (Oxford). 2022 Nov 2;61(11):4263-4272. - PMID 35179569

7

Improving clinical paediatric research and learning from COVID-19 : recommendations by the Conect4Children expert advice group

enthalten in: Pediatric research | 2022

von Ramanan, A. | Modi, N. | de Wildt, S. | +40

ErratumIn: Pediatr Res. 2023 Dec;94(6):2121. - PMID 37264139

8

Efficacy and safety of baricitinib plus standard of care for the treatment of critically ill hospitalised adults with COVID-19 on invasive mechanical ventilation or extracorporeal membrane oxygenation : an exploratory, randomised, placebo-controlled trial

enthalten in: The Lancet. Respiratory medicine | 2022

von Ely, E. | Ramanan, A. | Kartman, C. | +25

CommentIn: Lancet Respir Med. 2022 Apr;10(4):314-315. - PMID 35123659

9

Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER) : a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial

enthalten in: The Lancet. Respiratory medicine | 2021

von Marconi, V. | Ramanan, A. | de Bono, S. | +105

CommentIn: Lancet Respir Med. 2021 Dec;9(12):1349-1351. - PMID 34480862

10

Baricitinib plus Standard of Care for Hospitalised Adults with COVID-19 on Invasive Mechanical Ventilation or Extracorporeal Membrane Oxygenation: Results of a Randomised, Placebo-Controlled Trial

enthalten in: bioRxiv.org | 2021

von Ely, E. | Ramanan, A. | Kartman, C. | +7